This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
5mg | $250 | To Be Confirmed |
10mg | $450 | To Be Confirmed |
25mg | $800 | To Be Confirmed |
50mg | $1300 | To Be Confirmed |
Cat #: V26877 CAS #: 1316755-17-5 Purity ≥ 99%
Description: Olodanrigan sodium (EMA401; PD126055; EMA-401), a novel, orally bioavailable, peripherally restricted and highly selective AT2R (angiotensin II type 2 receptor) antagonist, can be potentially used for treatment of postherpetic neuralgia (PHN). Inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons. It is being developed as a neuropathic pain therapeutic agent.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Formula | C32H28NNaO5 |
---|---|
CAS No. | 1316755-17-5 |
SMILES Code | O=C([C@H]1N(C(C(C2=CC=CC=C2)C3=CC=CC=C3)=O)CC4=C(C(OCC5=CC=CC=C5)=C(OC)C=C4)C1)[O-].[Na+] |
Synonyms | EMA401; PD-126055; EMA-401; PD 126055; EMA 401; EMA401 sodium; PD126055 |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.